Company: INDP
Filing Date: 2025-08-13
Form Type: 8-K
Source: 0001641172-25-023332
Chunk: 0

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-08-13
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item       Results                                 

On
August 13, 2025, Indaptus Therapeutics, Inc. (the “ Company”) issued a press release announcing its financial results for
the quarter ended June 30, 2025. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and
is incorporated herein by reference.

The
information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that
Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended,
or the Exchange Act, except as expressly set forth by specific reference in such filing.